A D Horsch1, J W Dankbaar2, T A Stemerdink2, E Bennink2, T van Seeters2, L J Kappelle3, J Hofmeijer4, H W de Jong2, Y van der Graaf5, B K Velthuis2. 1. From the Departments of Radiology (A.D.H., J.W.D., T.A.S., E.B., T.v.S., H.W.d.J., B.K.V.) alexanderhorsch@gmail.com. 2. From the Departments of Radiology (A.D.H., J.W.D., T.A.S., E.B., T.v.S., H.W.d.J., B.K.V.). 3. Neurology (L.J.K.), Utrecht Stroke Center, University Medical Center Utrecht, Utrecht, the Netherlands. 4. Department of Neurology (J.H.), Rijnstate Hospital, Arnhem, the Netherlands. 5. Julius Center for Health Sciences and Primary Care (Y.v.d.G.), Utrecht, the Netherlands.
Abstract
BACKGROUND AND PURPOSE: Prominent space-occupying cerebral edema is a devastating complication occurring in some but not all patients with large MCA infarcts. It is unclear why differences in the extent of edema exist. Better knowledge of factors related to prominent edema formation could aid treatment strategies. This study aimed to identify variables associated with the development of prominent edema in patients with large MCA infarcts. MATERIALS AND METHODS: From the Dutch Acute Stroke Study (DUST), 137 patients were selected with large MCA infarcts on follow-up NCCT (3 ± 2 days after stroke onset), defined as ASPECTS ≤4. Prominent edema was defined as a midline shift of ≥5 mm on follow-up. Admission patient and treatment characteristics were collected. Admission CT parameters used were ASPECTS on NCCT and CBV and MTT maps, and occlusion site, clot burden, and collaterals on CTA. Permeability on admission CTP, and day 3 recanalization and reperfusion statuses were obtained if available. Unadjusted and adjusted (age and NIHSS) odds ratios were calculated for all variables in relation to prominent edema. RESULTS: Prominent edema developed in 51 patients (37%). Adjusted odds ratios for prominent edema were higher with lower ASPECTS on NCCT (adjusted odds ratio, 1.32; 95% CI, 1.13-1.55) and CBV (adjusted odds ratio, 1.26; 95% CI, 1.07-1.49), higher permeability (adjusted odds ratio, 2.35; 95% CI, 1.30-4.24), more proximal thrombus location (adjusted odds ratio, 3.40; 95% CI, 1.57-7.37), higher clot burden (adjusted odds ratio, 2.88; 95% CI, 1.11-7.45), and poor collaterals (adjusted odds ratio, 3.93; 95% CI, 1.78-8.69). CONCLUSIONS: Extensive proximal occlusion, poor collaterals, and larger ischemic deficits with higher permeability play a role in the development of prominent edema in large MCA infarcts.
BACKGROUND AND PURPOSE: Prominent space-occupying cerebral edema is a devastating complication occurring in some but not all patients with large MCA infarcts. It is unclear why differences in the extent of edema exist. Better knowledge of factors related to prominent edema formation could aid treatment strategies. This study aimed to identify variables associated with the development of prominent edema in patients with large MCA infarcts. MATERIALS AND METHODS: From the Dutch Acute Stroke Study (DUST), 137 patients were selected with large MCA infarcts on follow-up NCCT (3 ± 2 days after stroke onset), defined as ASPECTS ≤4. Prominent edema was defined as a midline shift of ≥5 mm on follow-up. Admission patient and treatment characteristics were collected. Admission CT parameters used were ASPECTS on NCCT and CBV and MTT maps, and occlusion site, clot burden, and collaterals on CTA. Permeability on admission CTP, and day 3 recanalization and reperfusion statuses were obtained if available. Unadjusted and adjusted (age and NIHSS) odds ratios were calculated for all variables in relation to prominent edema. RESULTS: Prominent edema developed in 51 patients (37%). Adjusted odds ratios for prominent edema were higher with lower ASPECTS on NCCT (adjusted odds ratio, 1.32; 95% CI, 1.13-1.55) and CBV (adjusted odds ratio, 1.26; 95% CI, 1.07-1.49), higher permeability (adjusted odds ratio, 2.35; 95% CI, 1.30-4.24), more proximal thrombus location (adjusted odds ratio, 3.40; 95% CI, 1.57-7.37), higher clot burden (adjusted odds ratio, 2.88; 95% CI, 1.11-7.45), and poor collaterals (adjusted odds ratio, 3.93; 95% CI, 1.78-8.69). CONCLUSIONS: Extensive proximal occlusion, poor collaterals, and larger ischemic deficits with higher permeability play a role in the development of prominent edema in large MCA infarcts.
Authors: Brian P Walcott; Jennifer C Miller; Churl-Su Kwon; Sameer A Sheth; Marc Hiller; Carolyn A Cronin; Lee H Schwamm; J Marc Simard; Kristopher T Kahle; W Taylor Kimberly; Kevin N Sheth Journal: Neurocrit Care Date: 2014-08 Impact factor: 3.210
Authors: Edwin Bennink; Alan J Riordan; Alexander D Horsch; Jan Willem Dankbaar; Birgitta K Velthuis; Hugo W de Jong Journal: J Cereb Blood Flow Metab Date: 2013-07-24 Impact factor: 6.200
Authors: Hesna Bektas; Tzu-Ching Wu; Mallikarjunarao Kasam; Nusrat Harun; Clark W Sitton; James C Grotta; Sean I Savitz Journal: Stroke Date: 2010-09-16 Impact factor: 7.914
Authors: Jeannette Hofmeijer; L Jaap Kappelle; Ale Algra; G Johan Amelink; Jan van Gijn; H Bart van der Worp Journal: Lancet Neurol Date: 2009-03-05 Impact factor: 44.182
Authors: Tom van Seeters; Geert Jan Biessels; Irene C van der Schaaf; Jan Willem Dankbaar; Alexander D Horsch; Merel J A Luitse; Joris M Niesten; Willem P T M Mali; L Jaap Kappelle; Yolanda van der Graaf; Birgitta K Velthuis Journal: BMC Neurol Date: 2014-02-25 Impact factor: 2.474
Authors: Wolfgang G Kunz; Wieland H Sommer; Christopher Höhne; Matthias P Fabritius; Felix Schuler; Franziska Dorn; Ahmed E Othman; Felix G Meinel; Louisa von Baumgarten; Maximilian F Reiser; Birgit Ertl-Wagner; Kolja M Thierfelder Journal: J Cereb Blood Flow Metab Date: 2017-01-13 Impact factor: 6.200
Authors: W Taylor Kimberly; Bruna Garbugio Dutra; Anna M M Boers; Heitor C B R Alves; Olvert A Berkhemer; Lucie van den Berg; Kevin N Sheth; Yvo B W E M Roos; Aad van der Lugt; Ludo F M Beenen; Diederik W J Dippel; Wim H van Zwam; Robert J van Oostenbrugge; Hester F Lingsma; Henk Marquering; Charles B L M Majoie Journal: JAMA Neurol Date: 2018-04-01 Impact factor: 18.302
Authors: Hossein Mohammadian Foroushani; Ali Hamzehloo; Atul Kumar; Yasheng Chen; Laura Heitsch; Agnieszka Slowik; Daniel Strbian; Jin-Moo Lee; Daniel S Marcus; Rajat Dhar Journal: Neurocrit Care Date: 2020-07-29 Impact factor: 3.210
Authors: Frans Kauw; Edwin Bennink; Hugo W A M de Jong; L Jaap Kappelle; Alexander D Horsch; Birgitta K Velthuis; Jan W Dankbaar Journal: Stroke Date: 2019-05-16 Impact factor: 7.914
Authors: Matthias P Fabritius; Paul Reidler; Matthias F Froelich; Lukas T Rotkopf; Thomas Liebig; Lars Kellert; Katharina Feil; Steffen Tiedt; Philipp M Kazmierczak; Kolja M Thierfelder; Daniel Puhr-Westerheide; Wolfgang G Kunz Journal: J Am Heart Assoc Date: 2019-10-19 Impact factor: 5.501